Related Experiment Video

Updated: Jul 3, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Endocrine therapy of metastatic breast cancer

Laura Rodríguez Lajusticia1, Miguel Martín Jiménez, Sara López-Tarruella Cobo

  • 1Servicio de Oncología Médica, Hospital Clínico Universitario San Carlos, Madrid, Spain. laura.rodriguez@salud.madrid.org

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|August 1, 2008
PubMed

Insights

This review explores endocrine therapies for metastatic breast cancer, detailing strategies to overcome resistance and treatment choices based on patient profiles and hormone receptor status.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Breast cancer progression is influenced by estrogen and growth factor receptor pathways.
  • Understanding these interactions is key to managing endocrine therapy response and resistance.
  • Metastatic breast cancer treatment requires tailored endocrine strategies.

Purpose of the Study:

  • To review current endocrine therapy strategies for metastatic breast cancer.
  • To analyze methods for overcoming endocrine resistance.
  • To outline treatment choices for diverse clinical scenarios.

Main Methods:

  • Literature review of clinical studies and biological mechanisms.
  • Analysis of endocrine therapy combinations and resistance pathways.
  • Focus on treatment selection for metastatic breast cancer.

Main Results:

  • Endocrine therapy is a primary option for select patients, even with low estrogen receptor expression.
  • Premenopausal patients may benefit from ovarian suppression and tamoxifen; postmenopausal patients from aromatase inhibitors.
  • Chemotherapy is reserved for hormone-unresponsive or resistant cases.

Conclusions:

  • Tailored endocrine therapy strategies are crucial for managing metastatic breast cancer.
  • Combinations and novel approaches are being investigated to overcome resistance.
  • Treatment decisions should consider menopausal status, disease progression, and receptor expression.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...